{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:57Z","timestamp":1761895557496},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T00:00:00Z","timestamp":1349222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1038\/ejhg.2012.216","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T14:39:51Z","timestamp":1349275191000},"page":"4-4","source":"Crossref","is-referenced-by-count":2,"title":["Clinical utility gene card for: familial polycythaemia vera"],"prefix":"10.1038","volume":"21","author":[{"given":"Kais","family":"Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galit","family":"Granot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Shpilberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,3]]},"reference":[{"key":"BFejhg2012216_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP et al: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144\u20131148.","journal-title":"Nature"},{"key":"BFejhg2012216_CR2","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.exphem.2009.07.005","volume":"37","author":"K Hussein","year":"2009","unstructured":"Hussein K, Bock O, Theophile K et al: JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Exp Hematol 2009; 37: 1186\u20131193.","journal-title":"Exp Hematol"},{"key":"BFejhg2012216_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1182\/blood-2005-12-4852","volume":"108","author":"C Bellann\u00e9-Chantelot","year":"2006","unstructured":"Bellann\u00e9-Chantelot C, Chaumarel I, Labopin M et al: Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders. Blood 2006; 108: 346\u2013352.","journal-title":"Blood"},{"key":"BFejhg2012216_CR4","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1038\/sj.leu.2404846","volume":"21","author":"K Hussein","year":"2007","unstructured":"Hussein K, Bock O, Ballmaier M et al: Familial polycythemia vera with non-germline JAK2(V617F) mutation sparing the abnormal and clonal granulopoiesis. Leukemia 2007; 21: 2566\u20132568.","journal-title":"Leukemia"},{"key":"BFejhg2012216_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1056\/NEJMoa065202","volume":"356","author":"LM Scott","year":"2007","unstructured":"Scott LM, Tong W, Levine RL et al: JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007; 356: 459\u2013468.","journal-title":"N Engl J Med"},{"key":"BFejhg2012216_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2353\/jmoldx.2009.080114","volume":"11","author":"W Ma","year":"2009","unstructured":"Ma W, Kantarjian H, Zhang X et al: Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias. Mol Diagn 2009; 11: 49\u201353.","journal-title":"Mol Diagn"},{"key":"BFejhg2012216_CR7","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3324\/haematol.11643","volume":"92","author":"MJ Percy","year":"2007","unstructured":"Percy MJ, Scott LM, Erber WN et al: The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Haematologica 2007; 92: 1607\u20131614.","journal-title":"Haematologica"},{"key":"BFejhg2012216_CR8","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1182\/blood-2007-07-101576","volume":"111","author":"D Pietra","year":"2008","unstructured":"Pietra D, Li S, Brisci A et al: Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2008; 111: 1686\u20131689.","journal-title":"Blood"},{"key":"BFejhg2012216_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ng.342","volume":"41","author":"O Kilpivaara","year":"2009","unstructured":"Kilpivaara O, Mukherjee S, Schram AM et al: A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 2009; 41: 455\u2013459.","journal-title":"Nat Genet"},{"key":"BFejhg2012216_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/ng.334","volume":"41","author":"AV Jones","year":"2009","unstructured":"Jones AV, Chase A, Silver RT et al: JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 2009; 41: 446\u2013449.","journal-title":"Nat Genet"},{"key":"BFejhg2012216_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/ng.341","volume":"41","author":"D Olcaydu","year":"2009","unstructured":"Olcaydu D, Harutyunyan A, Jager R et al: A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 2009; 41: 450\u2013454.","journal-title":"Nat Genet"},{"key":"BFejhg2012216_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3324\/haematol.2010.034488","volume":"96","author":"D Olcaydu","year":"2011","unstructured":"Olcaydu D, Rumi E, Harutyunyan A et al: The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms. Haematologica 2011; 96: 367\u2013374.","journal-title":"Haematologica"},{"key":"BFejhg2012216_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1182\/blood-2009-01-197525","volume":"114","author":"C Saint-Martin","year":"2009","unstructured":"Saint-Martin C, Leroy G, Delhommeau F et al: Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. Blood 2009; 114: 1628\u20131632.","journal-title":"Blood"},{"key":"BFejhg2012216_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/leu.2009.47","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Pardanani A, Lim KH et al: TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 2009; 23: 905\u2013911.","journal-title":"Leukemia"},{"key":"BFejhg2012216_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2141.2010.08551.x","volume":"153","author":"E Albiero","year":"2011","unstructured":"Albiero E, Ruggeri M, Fortuna S et al: Analysis of the oxygen sensing pathway genes in familial chronic myeloproliferative neoplasms and identification of a novel EGLN1 germ-line mutation. Br J Haematol 2011; 153: 405\u2013408.","journal-title":"Br J Haematol"},{"key":"BFejhg2012216_CR16","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00277-009-0745-3","volume":"88","author":"U Bacher","year":"2009","unstructured":"Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C : Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS\/MPN category. Ann Hematol 2009; 88: 1207\u20131213.","journal-title":"Ann Hematol"},{"key":"BFejhg2012216_CR17","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1182\/blood-2003-03-0885","volume":"102","author":"R Kralovics","year":"2003","unstructured":"Kralovics R, Stockton DW, Prchal JT : Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood 2003; 102: 3793\u20133796.","journal-title":"Blood"},{"key":"BFejhg2012216_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.leu.2404081","volume":"20","author":"H Quentmeier","year":"2006","unstructured":"Quentmeier H, MacLeod RA, Zaborski M, Drexler HG : JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. Leukemia 2006; 20: 471\u2013476.","journal-title":"Leukemia"},{"key":"BFejhg2012216_CR19","volume-title":"WHO classification of tumours of hematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL et al. (eds): WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: IARC press, 2008, vol 4."},{"key":"BFejhg2012216_CR20","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1200\/JCO.2007.12.6896","volume":"25","author":"E Rumi","year":"2007","unstructured":"Rumi E, Passamonti F, Della Porta MG et al: Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation. J Clin Oncol 2007; 25: 5630\u20135635.","journal-title":"J Clin Oncol"},{"key":"BFejhg2012216_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/ajh.22212","volume":"87","author":"LA Anderson","year":"2012","unstructured":"Anderson LA, Duncombe AS, Hughes M, Mills ME, Wilson JC, McMullin MF : Environmental, lifestyle, and familial\/ethnic factors associated with myeloproliferative neoplasms. Am J Hematol 2012; 87: 175\u2013182.","journal-title":"Am J Hematol"},{"key":"BFejhg2012216_CR22","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1182\/blood-2008-08-175620","volume":"112","author":"K Kelly","year":"2008","unstructured":"Kelly K, McMahon C, Langabeer S, Eliwan H, O\u2018Marcaigh A, Smith OP : Congenital JAK2V617F polycythemia vera: where does the genotype-phenotype diversity end? Blood 2008; 112: 4356\u20134357.","journal-title":"Blood"},{"key":"BFejhg2012216_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/hon.863","volume":"26","author":"E Rumi","year":"2008","unstructured":"Rumi E : Familial chronic myeloproliferative disorders: the state of the art. Hematol Oncol 2008; 26: 131\u2013138.","journal-title":"Hematol Oncol"},{"key":"BFejhg2012216_CR24","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1182\/blood-2008-03-143602","volume":"112","author":"O Landgren","year":"2008","unstructured":"Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Bj\u00f6rkholm M : Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11\u2009039 patients with myeloproliferative neoplasms in Sweden. Blood 2008; 112: 2199\u20132204.","journal-title":"Blood"},{"key":"BFejhg2012216_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00277-009-0758-y","volume":"88","author":"H Cario","year":"2009","unstructured":"Cario H, McMullin MF, Pahl HL : Clinical and hematological presentation of children and adolescents with polycythemia vera. Ann Hematol 2009; 88: 713\u2013719.","journal-title":"Ann Hematol"},{"key":"BFejhg2012216_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ejhg.2011.252","volume":"20","author":"K Hussein","year":"2012","unstructured":"Hussein K, Percy M, McMullin MF : Clinical utility gene card for: Familial erythrocytosis. Eur J Hum Genet 2012; 20: e1\u2013e4.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012216","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2012216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:06:38Z","timestamp":1684429598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2012216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,3]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["BFejhg2012216"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2012.216","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,3]]}}}